214 related articles for article (PubMed ID: 26241226)
1. The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients.
Barzilai M; Jacob G
Rambam Maimonides Med J; 2015 Jul; 6(3):. PubMed ID: 26241226
[TBL] [Abstract][Full Text] [Related]
2. Continuous progression of orthostatic tachycardia as a further feature of the postural tachycardia syndrome.
Diehl RR
Pacing Clin Electrophysiol; 2005 Sep; 28(9):975-9. PubMed ID: 16176538
[TBL] [Abstract][Full Text] [Related]
3. Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature.
Tahir F; Bin Arif T; Majid Z; Ahmed J; Khalid M
Cureus; 2020 Apr; 12(4):e7868. PubMed ID: 32489723
[TBL] [Abstract][Full Text] [Related]
4. Variant cardiovascular regulation in children with postural tachycardia syndrome.
Yoshida S; Tanaka H; Nakao R; Okamoto N; Kajiura M; Kanbara Y; Azuma S; Tamai H
Pediatr Int; 2014 Jun; 56(3):328-35. PubMed ID: 24417890
[TBL] [Abstract][Full Text] [Related]
5. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion.
Stewart JM
Pediatr Res; 2000 Aug; 48(2):218-26. PubMed ID: 10926298
[TBL] [Abstract][Full Text] [Related]
6. [Time-dependent heart rate variability in the head-up tilt test in children with postural orthostatic tachycardia syndrome].
Ran J; Wang C; Zou RM; Wu LJ; Lin P; Li F; Xu Y
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Oct; 17(10):1070-3. PubMed ID: 26483226
[TBL] [Abstract][Full Text] [Related]
7. Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience.
Ruzieh M; Sirianni N; Ammari Z; Dasa O; Alhazmi L; Karabin B; Grubb B
Pacing Clin Electrophysiol; 2017 Nov; 40(11):1242-1245. PubMed ID: 28846151
[TBL] [Abstract][Full Text] [Related]
8. Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review.
Gee ME; Watkins AK; Brown JN; Young EJA
Am J Cardiovasc Drugs; 2018 Jun; 18(3):195-204. PubMed ID: 29330767
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of heart rate reduction with resumption of supine position in the postural tachycardia syndrome: factors influencing recovery.
Mayuga KA; Gaw CE; Tatsuoka C; Fouad-Tarazi F
Open Cardiovasc Med J; 2013; 7():36-9. PubMed ID: 23802020
[TBL] [Abstract][Full Text] [Related]
10. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.
Taub PR; Zadourian A; Lo HC; Ormiston CK; Golshan S; Hsu JC
J Am Coll Cardiol; 2021 Feb; 77(7):861-871. PubMed ID: 33602468
[TBL] [Abstract][Full Text] [Related]
11. Differences in cardiac autonomic function contributes to heart rate abnormalities in POTS and IST.
Corkal JC; Palamarchuk I; Kimpinski K
Auton Neurosci; 2014 Dec; 186():85-90. PubMed ID: 25277318
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Active Sitting Test and Head-Up Tilt Test for Diagnosis of Postural Tachycardia Syndrome in Children and Adolescents.
Cai H; Wang S; Zou R; Liu P; Li F; Wang Y; Wang C
Front Pediatr; 2021; 9():691390. PubMed ID: 34604136
[No Abstract] [Full Text] [Related]
13. Postural Tachycardia Syndrome and COVID-19: Focus on Ivabradine Therapy.
Dixit K; Frishman WH
Cardiol Rev; 2024 May-Jun 01; 32(3):279-284. PubMed ID: 36729924
[TBL] [Abstract][Full Text] [Related]
14. Low Sensitivity of Abbreviated Tilt Table Testing for Diagnosing Postural Tachycardia Syndrome in Adults With ME/CFS.
van Campen CLMC; Rowe PC; Visser FC
Front Pediatr; 2018; 6():349. PubMed ID: 30505831
[No Abstract] [Full Text] [Related]
15. Hemodynamic profile and heart rate variability in hyperadrenergic versus non-hyperadrenergic postural orthostatic tachycardia syndrome.
Crnošija L; Krbot Skorić M; Adamec I; Lovrić M; Junaković A; Mišmaš A; Miletić V; Šprljan Alfirev R; Pavelić A; Habek M
Clin Neurophysiol; 2016 Feb; 127(2):1639-1644. PubMed ID: 26386646
[TBL] [Abstract][Full Text] [Related]
16. Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats.
Silva FC; Paiva FA; Müller-Ribeiro FC; Caldeira HM; Fontes MA; de Menezes RC; Casali KR; Fortes GH; Tobaldini E; Solbiati M; Montano N; Dias Da Silva VJ; Chianca DA
Front Physiol; 2016; 7():305. PubMed ID: 27507948
[TBL] [Abstract][Full Text] [Related]
17. Ivabradine effects on COVID-19-associated postural orthostatic tachycardia syndrome: a single center prospective study.
Abdelnabi M; Saleh Y; Ahmed A; Benjanuwattra J; Leelaviwat N; Almaghraby A
Am J Cardiovasc Dis; 2023; 13(3):162-167. PubMed ID: 37469536
[TBL] [Abstract][Full Text] [Related]
18. Menstrual cycle phase does not affect sympathetic neural activity in women with postural orthostatic tachycardia syndrome.
Stickford AS; VanGundy TB; Levine BD; Fu Q
J Physiol; 2015 May; 593(9):2131-43. PubMed ID: 25656420
[TBL] [Abstract][Full Text] [Related]
19. Autonomic activity and biomarker behavior in supine position and after passive postural stress in different orthostatic intolerance syndromes.
Freitas J; Azevedo E; Santos R; Maciel MJ; Rocha-Gonçalves F
Rev Port Cardiol; 2015 Sep; 34(9):543-9. PubMed ID: 26320094
[TBL] [Abstract][Full Text] [Related]
20. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome.
Lambert E; Eikelis N; Esler M; Dawood T; Schlaich M; Bayles R; Socratous F; Agrotis A; Jennings G; Lambert G; Vaddadi G
Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):103-9. PubMed ID: 19808400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
